Article
Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response - Nature Medicine
Rating:
0.0
Views:
66
Likes:
1
Library:
1
Contemporary chemotherapy for childhood acute lymphoblastic leukemia (ALL) is risk-adapted based on clinical features, leukemia genomics and minimal residual disease (MRD); however, the pharmacological basis of these prognostic variables remains unclear.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value